Metro Health Stops Use Of J & J Vaccine For Women Under 50
Metro Health-University of Michigan Health says it will not offer the Johnson & Johnson vaccine to women under 50.
Last month, health officials paused use of the shot for 11 days after receiving reports that some women between the ages of 18 and 48 had suffered an extremely rare, but severe clotting disorder within weeks of taking the vaccine. The Centers for Disease Control and Prevention reported out of 8 million doses administered, 15 cases resulted in the clotting disorder.
Fox 17 reported that a spokeswoman for Metro Health said,
"while the risk of a blood clot is extremely low, Metro Health’s vaccine leadership team agreed the only way to eliminate the risk is to stop using the J&J vaccine in the concentrated age group of women."